Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Vaxart, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 98 | 17 | −81 |
| Shares | 22.8M | 2.34M | −20.5M (−89.8%) |
| Value | $10.3M | $839.9K | −$9.47M (−91.8%) |
New holders (3)
Institutions that held Vaxart, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baader Bank INC | 12,091 | $2.73K | 0.00% |
| Rockefeller Capital Management L.P. | 1,175 | $429 | 0.00% |
| Farther Finance Advisors, LLC | 27 | $10 | 0.00% |
Sold out (84)
Institutions that held Vaxart, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.